Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, Changyoun, Ho, Dong-Hwan, Suk, Ji-Eun, You, Sungyong, Michael, Sarah, Kang, Junghee, Joong Lee, Sung, Masliah, Eliezer +3 more·2013·Nature Communications

DOI 10.1038/ncomms2534

Cited by (863)

Items 401–500 of 863

Pivotal Role of Fyn Kinase in Parkinson’s Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?
Efthalia Angelopoulou, Yam Nath Paudel, Thomas Henry Julian, Mohd. Farooq Shaikh, Christina Piperi · 2020 · Molecular Neurobiology
Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
Laura Boi, Augusta Pisanu, Maria Francesca Palmas, Giuliana Fusco, Ezio Carboni, Maria Antonietta Casu, Valentina Satta, María Scherma, Elżbieta Janda, Ignazia Mocci et al. · 2020 · International Journal of Molecular Sciences
Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
Gundersen, Vidar · 2021 · Frontiers in Neuroscience
Creatine supplementation with exercise reduces α-synuclein oligomerization and necroptosis in Parkinson's disease mouse model
Yea‐Hyun Leem, Jin‐Sun Park, Jung-Eun Park, Do‐Yeon Kim, Hee-Sun Kim · 2024 · The Journal of Nutritional Biochemistry
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
Marika Doucet, Aadil El-Turabi, Franziska Zabel, Benjamin H.M. Hunn, Nora Bengoa‐Vergniory, Milena Cioroch, Mauricio Ramm, Amy M. Smith, Ariane Cruz Gomes, Gustavo Cabral de Miranda et al. · 2017 · PLoS ONE
Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models
Michiyo Iba, Changyoun Kim, Jazmin B. Florio, Michael Mante, Anthony Adame, Edward M. Rockenstein, Somin Kwon, Robert A. Rissman, Eliezer Masliah · 2020 · Frontiers in Neuroscience · Retracted
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, Thuy Thi, Kim, Yun Joong, Ma, Hyeo-il, Kim, Young Eun · 2022 · Journal of Movement Disorders
Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
Sean Miller, Cameron E. Campbell, Helen A. Jimenez-Corea, Guanhui Wu, Robert A Logan · 2022 · Frontiers in Neuroscience
Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review
Mobina Fathi, Kimia Ghazi Vakili, Shirin Yaghoobpoor, Mohammad Sadegh Qadirifard, Mohammadreza Kosari, Navid Naghsh, Afsaneh Asgari Taei, Andis Klegeris, Mina Dehghani, Ashkan Bahrami et al. · 2022 · Frontiers in Aging Neuroscience
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
Berenice A. Gutierrez, Agenor Limón · 2022 · Biomedicines
Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease
Manuj Ahuja, Navneet Ammal Kaidery, Debashis Dutta, Otis C. Attucks, Eliot H. Kazakov, Irina G. Gazaryan, Mitsuyo Matsumoto, Kazuhiko Igarashi, Sudarshana M. Sharma, Bobby Thomas · 2022 · Antioxidants
ΔPK oncolytic activity includes modulation of the tumour cell milieu
Dominique R. Bollino, Aric Colunga, Baiquan Li, Laure Aurelian · 2015 · Journal of General Virology
Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
Wang, Zhifu, Wang, Qi, Li, Shihua, Li, Xiao-Jiang, Yang, Weili, He, Dajian · 2023 · Frontiers in Aging Neuroscience
Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease
Yiming Wang, Yun Fei Xia, Liang Kou, Sijia Yin, Xiaosa Chi, Jingwen Li, Yadi Sun, Jiawei Wu, Qiulu Zhou, Wenkai Zou et al. · 2023 · Neurobiology of Disease
Reciprocal signals between microglia and neurons regulate α-synuclein secretion by exophagy through a neuronal cJUN-N-terminal kinase-signaling axis
Dan Ploug Christensen, Patrick Ejlerskov, Izabela Rasmussen, Frederik Vilhardt · 2016 · Journal of Neuroinflammation
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
Katarzyna Z. Kuter, Maria Angela Cenci, Anna Rosa Carta · 2020 · Progress in brain research
Phosphorylated α-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson’s disease through TLR2/NF-κB pathway
Sun, Li, Jiang, Wen-Wen, Wang, Ye, Yuan, Yong-Sheng, Rong, Zhe, Wu, Jing, Fan, Yi, Lu, Ming, Zhang, Ke-Zhong · 2021 · Cell Death Discovery
Intestinal microbiota: A promising therapeutic target for hypertension
Dating Sun, Hui Xiang, Jiangtao Yan, Liqun He · 2022 · Frontiers in Cardiovascular Medicine
Deletion of Calhm2 alleviates MPTP-induced Parkinson's disease pathology by inhibiting EFHD2-STAT3 signaling in microglia
Xuena Bo, Fei Xie, Jingdan Zhang, Run-Ze Gu, Xiaoheng Li, Shuoshuo Li, Zengqiang Yuan, Jinbo Cheng · 2023 · Theranostics
Caspases orchestrate microglia instrumental functions
Xianli Shen, Jose Luis Venero, Bertrand Joseph, Miguel Ángel Burguillos · 2018 · Progress in Neurobiology
Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy
Taeyeon Kim, Elvira Valera, Paula Desplats · 2019 · Molecular Neurobiology
Models of multiple system atrophy
He-Jin Lee, Diadem Ricarte, Darlene Mae Ortiz, Seung‐Jae Lee · 2019 · Experimental & Molecular Medicine
Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
Jung Hwan Shin, Han‐Joon Kim, Beomseok Jeon · 2019 · Journal of Movement Disorders
GT1b functions as a novel endogenous agonist of toll‐like receptor 2 inducing neuropathic pain
Hyoungsub Lim, Jaesung Lee, Byunghyun You, Jae Hoon Oh, Hyuck Jun Mok, Yoo Sung Kim, Bo‐Eun Yoon, Byung Gon Kim, Seung Keun Back, Jong‐Sang Park et al. · 2020 · The EMBO Journal
Inflammation in Experimental Models of α ‐Synucleinopathies
Ashley S. Harms, Jeffrey H. Kordower, Alessandro Sette, Cecilia S. Lindestam Arlehamn, David L. Sulzer, Robert H. Mach · 2020 · Movement Disorders
The Role of Glial Mitochondria in α-Synuclein Toxicity
Yu‐Mi Jeon, Younghwi Kwon, Myungjin Jo, Shinrye Lee, Seyeon Kim, Hyung‐Jun Kim · 2020 · Frontiers in Cell and Developmental Biology
Proteostasis Perturbations and Their Roles in Causing Sterile Inflammation and Autoinflammatory Diseases
Jonas Johannes Papendorf, Elke Krüger, Frédéric Ebstein · 2022 · Cells
Brain-to-gut trafficking of alpha-synuclein by CD11c+ cells in a mouse model of Parkinson’s disease
Rhonda L. McFleder, Anastasiia Makhotkina, Janos Groh, Ursula Keber, Fabian Imdahl, Josefina Peña Mosca, Alina Peteranderl, Jingjing Wu, Sawako Tabuchi, Jan Hoffmann et al. · 2023 · Nature Communications
A multi-platform analysis of human gingival crevicular fluid reveals ferroptosis as a relevant regulated cell death mechanism during the clinical progression of periodontitis
Alfredo Torres, María Angélica Michea, Ákos Végvári, Marion Arce, Valentina Pérez, Marcela Alcota, Alicia Morales, Rolando Vernal, Mauricio Budini, Roman A. Zubarev et al. · 2024 · International Journal of Oral Science
Microbiome-based therapeutics for Parkinson's disease
Adam M. Hamilton, Ian N Krout, Alexandria C. White, Timothy Robert Sampson · 2024 · Neurotherapeutics
Microglia-driven inflammation induces progressive tauopathies and synucleinopathies
Sang Hwan Lee, Eun-Jin Bae, Sung Jun Park, Seung‐Jae Lee · 2025 · Experimental & Molecular Medicine
Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
Georgia Kouroupi, Nasia Antoniou, Kanella Prodromidou, Era Taoufik, Rebecca Matsas · 2020 · International Journal of Molecular Sciences
LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease
You‐Cui Wang, Xiaoqin Zhang, Fenghua Chen, Leilei Chen, Jun Wang, Junxia Xie · 2021 · Journal of Inflammation Research
The PICK1/TLR4 complex on microglia is involved in the regulation of LPS-induced sepsis-associated encephalopathy
Lu Wang, Feihong Lin, Miao Ren, Xia Liu, Wenjing Xie, Anqi Zhang, Meizi Qian, Yunchang Mo, Junlu Wang, Ya Lv · 2021 · International Immunopharmacology
Long‐lasting pathological consequences of overexpression‐induced α‐synuclein spreading in the rat brain
Raffaella Rusconi, Ayşe Ulusoy, Helia Aboutalebi, Donato A. Di Monte · 2018 · Aging Cell
Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies
Hiroaki Sekiya, Tomoyasu Matsubara, Michael A. Deture, Dennis W. Dickson · 2025 · Molecular Neurodegeneration
Membrane Trafficking Illuminates a Path to Parkinson’s Disease
Takafumi Hasegawa, Naoto Sugeno, Akio Kikuchi, Toru Baba, Masashi Aoki · 2017 · The Tohoku Journal of Experimental Medicine
From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
Antonio Heras‐Garvin, Nadia Stefanova · 2020 · Frontiers in Synaptic Neuroscience
Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons
Shijun Wang, Chun‐Hsien Chu, Mingri Guo, Lulu Jiang, Hui Nie, Wei Zhang, Belinda C. Wilson, Yang Li, Tessandra Stewart, Jau‐Shyong Hong et al. · 2016 · Journal of Neuroinflammation
Convergent molecular defects underpin diverse neurodegenerative diseases
George K. Tofaris, Noel J. Buckley · 2018 · Journal of Neurology Neurosurgery & Psychiatry
Unraveling the transcriptomic signatures of Parkinson’s disease and major depression using single-cell and bulk data
Christiana C. Christodoulou, Anna Onisiforou, Panos Zanos, Eleni Zamba Papanicolaou · 2023 · Frontiers in Aging Neuroscience
Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
Somin Lim, Han‐Joon Kim, Dong‐Kyu Kim, Seung‐Jae Lee · 2018 · Progress in Neurobiology
Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity
Dafina M. Angelova, David R. Brown · 2018 · Biomolecules
Cellular Biology of Tau Diversity and Pathogenic Conformers
Sang‐Gyun Kang, Ghazaleh Eskandari‐Sedighi, Lenka Hromádková, Jiri Safar, David A. Westaway · 2020 · Frontiers in Neurology
On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases
Giuseppe Legname, Carlo Scialò · 2020 · Prion
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
Sonia George, Trevor Tyson, Nolwen L. Rey, Rachael T. C. Sheridan, Wouter Peelaerts, Katelyn Becker, Emily Schulz, Lindsay K. Meyerdirk, Amanda Rae Burmeister, Christian Ulrich von Linstow et al. · 2021 · Journal of Parkinson s Disease
Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands
Ferenc Bogár, Lívia Fülöp, Botond Penke · 2022 · Biomolecules
LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss
Dong Hwan Ho, Daleum Nam, Mi Kyoung Seo, Sung‐Woo Park, Wongi Seol, Ilhong Son · 2022 · Cells
Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in Neurodegeneration
Lucia Yi-Ru Chung, Yi‐Ting Lin, Chi Liu, Yi‐Cheng Tai, Han‐Yi Lin, Chin‐Hsien Lin, Ching‐Chow Chen · 2022 · Frontiers in Pharmacology
RETRACTED ARTICLE: Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD
Michiyo Iba, Ross A. McDevitt, Changyoun Kim, Roshni Roy, Dimitra Sarantopoulou, Ella Tommer, Byron Siegars, Michelle A. Sallin, Somin Kwon, Jyoti Misra Sen et al. · 2022 · Molecular Neurodegeneration · Retracted
Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity
Neal K. Bennett, Rebecca Chmielowski, Dalia S. Abdelhamid, Jonathan J. Faig, Nicola Louise Francis, Jean Baum, Zhiping P. Pang, Kathryn E. Uhrich, Prabhas V. Moghe · 2016 · Biomaterials
Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments
Marianne von Euler Chelpin, Thomas Vorup‐Jensen · 2017 · Scandinavian Journal of Immunology
New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
Jolene S.Y. Tan, Yinxia Chao, Olaf Rötzschke, Eng‐King Tan · 2020 · International Journal of Molecular Sciences
Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review)
Nianping Zhang, Zhaoli Yan, Xin Hua, Shuai Shao, Song Xue, Raymond Cespuglio, Shijun Wang · 2023 · Experimental and Therapeutic Medicine
Novel Insights into Parkin–Mediated Mitochondrial Dysfunction and “Mito-Inflammation” in α-Synuclein Toxicity. The Role of the cGAS–STING Signalling Pathway
Magdalena Gąssowska-Dobrowolska, Gabriela Olech-Kochańczyk, Carsten Culmsee, Agata Adamczyk · 2024 · Journal of Inflammation Research
Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
Helena Borland Madsen, Frederik Vilhardt · 2017 · International Journal of Molecular Sciences
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri · 2020 · Frontiers in Cell and Developmental Biology
Dose-related biphasic effect of the Parkinson’s disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein
Madiha Mohieldin Merghani, Mustafa Taleb Ardah, Mariam Al Shamsi, Tohru Kitada, M. Emdadul Haque · 2021 · NeuroToxicology
Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson’s Disease
Chao Gu, Yajing Chen, Yan Chen, Chun‐Feng Liu, Zengyan Zhu, Mei Wang · 2021 · Frontiers in Aging Neuroscience
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
Mai Mohamed Abdelmoaty, Jatin Machhi, Pravin Yeapuri, Farah Shahjin, Vikas S. Kumar, Katherine E. Olson, Rodney Lee Mosley, Howard Eliot Gendelman · 2022 · Clinical and Translational Medicine
Let’s make microglia great again in neurodegenerative disorders
Marie‐Victoire Guillot‐Sestier, Terrence Town · 2017 · Journal of Neural Transmission
Microbial amyloids in neurodegenerative amyloid diseases
Timothy Robert Sampson · 2023 · FEBS Journal
Lysosomal stress drives the release of pathogenic α-synuclein from macrophage lineage cells via the LRRK2-Rab10 pathway
Tetsuro Abe, Tomoki Kuwahara, Shoichi Suenaga, Maria Sakurai, Sho Takatori, Takeshi Iwatsubo · 2024 · iScience
Gut–brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration
Anchal Trisal, Ishika Singh, Geetika Garg, Khanak Jorwal, Abhishek Kumar Singh · 2024 · 3 Biotech
Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson’s disease
E. Kostuk, Jing-Li Cai, L. Iacovitti · 2018 · Journal of Neuroinflammation
Investigating the Convergent Mechanisms between Major Depressive Disorder and Parkinson’s Disease
Angela A. Tran, Myra De Smet, Gary Dean Grant, Tien Kheng Khoo, Dean L. Pountney · 2020 · Complex Psychiatry
Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases
Carl Gunnar Gottschalk, Daniel L. Peterson, Jan Armstrong, Konstance Kehl Knox, Avik Roy · 2023 · Infectious Agents and Cancer
Suppression of neuroinflammation and α-synuclein oligomerization by rotarod walking exercise in subacute MPTP model of Parkinson's disease
Yea‐Hyun Leem, Jin‐Sun Park, Jung-Eun Park, Doyoun Kim, Hee-Sun Kim · 2023 · Neurochemistry International
Elevated neuronal α-synuclein promotes microglia activation after spinal cord ischemic/reperfused injury
Hongfei Qiao, Qiaojun Zhang, Haifeng Yuan, Yali Li, Dong Wang, Rui Wang, Xijing He · 2015 · Neuroreport
Small Molecule Inhibition of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4)
Nathan E. Genung, Kevin M. Guckian · 2017 · Progress in medicinal chemistry
Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson’s Disease
Drobny, Alice, Ngo, Phuong A., Neurath, Markus F., Zunke, Friederike, López-Posadas, Rocío · 2021 · Frontiers in Medicine
Hippocampal proliferation is increased in presymptomatic Parkinson’s disease and due to microglia
Doorn, Karlijn J., Drukarch, Benjamin, van Dam, Anne-Marie, Lucassen, Paul J. · 2014 · Neural Plasticity
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
Jimenez-Ferrer, Itzia, Bäckström, Filip, Dueñas-Rey, Alfredo, Jewett, Michael, Boza-Serrano, Antonio, Luk, Kelvin C., Deierborg, Tomas, Swanberg, Maria · 2021 · Brain, Behavior, and Immunity
Alpha-Synuclein Neurobiology in Parkinson’s Disease: A Comprehensive Review of Its Role, Mechanisms, and Therapeutic Perspectives
Jamir Pitton Rissardo, Andrew J. McGarry, Yiwen Shi, Ana Letícia Fornari Caprara, George T. Kannarkat · 2025 · Brain Sciences
Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme
Pauline Mencke, Zoé Hanss, Ibrahim Boussaad, Pierre‐Emmanuel Sugier, Alexis Elbaz, Rejko Krüger · 2020 · Frontiers in Neurology
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
Jenny Valentina Garmendia, Claudia Valentina De Sanctis, Viswanath Das, Narendran Annadurai, Marián Hajdúch, Juan Bautista De Sanctis · 2023 · Current Neuropharmacology
PAR2-mediated epigenetic upregulation of α-synuclein contributes to the pathogenesis of Parkinson׳s disease
Ping Liu, Liang Sun, Xuli Zhao, Peng Zhang, Xuemei Zhao, Jian Zhang · 2014 · Brain Research
Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity
Dong Hwan Ho, Wongi Seol, Jin Hwan Eun, Ilhong Son · 2016 · Biochemical and Biophysical Research Communications
Toll-like receptor 2 confers partial neuroprotection during prion disease
Carroll, James A., Race, Brent, Williams, Katie, Chesebro, Bruce · 2018 · PLOS ONE
LRRK2 Mediates α-Synuclein-Induced Neuroinflammation and Ferroptosis through the p62-Keap1-Nrf2 Pathway in Parkinson’s Disease
Xinjie Liu, Zijian Zheng, Cheng Xue, Xiangrong Wang, Jianwei Li, Zheng Liu, Wenqiang Xin, Xinping Xu, Dongwei Zhou, Longping Yao et al. · 2025 · Inflammation
Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions
Julia Doroszkiewicz, Izabela Winkel, Barbara Mroczko · 2025 · Frontiers in Neuroscience
Emerging preclinical pharmacological targets for Parkinson's disease
Sandeep Vasant More, Dong‐Kug Choi · 2016 · Oncotarget
Alpha-Synuclein Handling by Microglia: Activating, Combating, and Worsening
Ning Song, Leilei Chen, Junxia Xie · 2021 · Neuroscience Bulletin
Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson’s disease
Laetitia Francelle, Joseph R. Mazzulli · 2022 · Brain Research
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Alexander J. Hull, Magda Luciana Atilano, Laith Gergi, Kerri J. Kinghorn · 2024 · Philosophical Transactions of the Royal Society B Biological Sciences
Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways
Patrícia Silva Guerreiro, Joana Esteves Coelho, Inês Sousa‐Lima, Maria Paula Macedo, Luísa Vaqueiro Lopes, Tiago F. Outeiro, Teresa Faria Pais · 2016 · NeuroMolecular Medicine
Target oxidative stress-induced disulfidptosis: novel therapeutic avenues in Parkinson’s disease
Junshi Zhang, Tingting Liu, Haojie Wu, Jianshe Wei, Qiumin Qu · 2025 · Molecular Brain
Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils
Karina Joppe, Lars Tatenhorst, Lucas Caldi Gomes, Shuyu Zhang, Mojan Parvaz, Eleonora Carboni, Anna‐Elisa Roser, Hazem Eldebakey, Mathias Bähr, Katarina Vogel‐Mikuš et al. · 2021 · Journal of Neurochemistry
α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an <i>in vitro</i> proof of concept study
Hurley, Michael J, Menozzi, Elisa, Koletsi, Sofia, Bates, Rachel, Gegg, Matthew E, Chau, Kai-Yin, Blottière, Hervé M, Macnaughtan, Jane, Schapira, Anthony H V · 2023 · Brain Communications
Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions
Anna C. Stoll, Christopher J. Kemp, Joseph R. Patterson, Jacob W. Howe, Kathy Steece‐Collier, Kelvin C. Luk, Caryl E. Sortwell, Matthew J. Benskey · 2024 · Neurobiology of Disease
Region-specific transcriptional signatures of brain aging in the absence of neuropathology at the single-cell level
Monica E. Mesecar, Megan F. Duffy, Dominic J. Acri, Jinhui Ding, Rebekah G. Langston, Syed I. Shah, Mike A. Nalls, Xylena Reed, Sonja W. Scholz, D. Thad Whitaker et al. · 2026 · npj Aging
TLR4 signaling mediates AP-1 activation in an MPTP-induced mouse model of Parkinson's disease
Xudong Zhao, Fa-Xiang Wang, Wenfu Cao, Yonghong Zhang, Yan Li · 2016 · International Immunopharmacology
Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Julia Teister, Fabian Anders, Sabine Gehrke-Beck, Sebastian Funke, Harald von Pein, Verena Prokosch, Norbert Pfeiffer, Franz H. Grus · 2017 · Scientific Reports
Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders
Silke Miller, Marı́a-Jesús Blanco · 2021 · RSC Medicinal Chemistry
Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy
Teresa Torre-Muruzabal, Anke Van der Perren, Audrey Coens, Géraldine Gelders, Anna Barber Janer, Sara Camacho-Garcia, Therése Klingstedt, K. Peter R. Nilsson, Nadia Stefanova, Ronald Melki et al. · 2022 · Brain
How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
Ziyi Zhang, Zhihui Liu, Ao Lv, Chenhui Fan · 2023 · Frontiers in Immunology
Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review
Paula M. Loveland, Jenny Jia Yu, Leonid P. Churilov, Nawaf Yassi, Rosie Watson · 2023 · International Journal of Molecular Sciences
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission
Lucia Lage, Ana Isabel Rodriguez-Perez, Begoña Villar‐Cheda, José Luis Labandeira-García, Antonio Dominguez‐Meijide · 2024 · npj Parkinson s Disease
Emerging roles of protein kinases in microglia-mediated neuroinflammation
Sun Hwa Lee, Kyoungho Suk · 2017 · Biochemical Pharmacology
Viral mimetic priming enhances α-synuclein-induced degeneration: Implications for Parkinson’s disease
Laura K. Olsen, Andrew G. Cairns, Jörgen Ådén, Niamh Moriarty, Sílvia Cabré, Verónica Alamilla, Fredrik Almqvist, Eilís Dowd, Declan Patrick McKernan · 2019 · Brain Behavior and Immunity